if the NIH ran a US$50m trial on data from a dozen patients... they'll easily fund this, espeically now knowing that this pandemic is far from over.
Moreso with an EUA dangling at the end of the trial... if successful, this treatment could be the back-stop to ending this pandemic... once patients know there is an effective treatment for those that get to the ICU, then it takes away the fear or dying from COVID and that is when the pandemic truly ends.
IMO the NIH will pay.
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-173
-
- There are more pages in this discussion • 236 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.055(4.66%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $4.824M | 4.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25589 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |